MicroRNA-335-5p Plays Dual Roles in Periapical Lesions by Complex Regulation Pathways

J Endod. 2017 Aug;43(8):1323-1328. doi: 10.1016/j.joen.2017.03.018. Epub 2017 Jun 1.

Abstract

Introduction: MicroRNA-335-5p has been reported to regulate osteogenic and chondrogenic differentiations of mesenchymal stem cells. The aim of this study was to explore the function and regulation mechanism of miR-335-5p in apical periodontitis (AP).

Methods: Total RNAs were extracted from human periodontal ligament fibroblasts (HPDLFs), 10 AP tissues, and 6 healthy periodontal ligament tissues using lysis buffer. Gene expression was detected using real-time polymerase chain reaction. The Dual Luciferase Assay (Promega, Madison, WI) was used to test miR-335-5p directly targeted urokinase-type plasminogen activator receptor (uPAR) and the receptor activator of nuclear factor kappa-B ligand (RANKL). Western Blot was used to detect protein expressions of RANKL, uPAR, and the fragile X-related 1 gene (FXR1). The enzyme-linked immunosorbent assay was used to detect the secretions of interleukin 6, tumor necrosis factor alpha, and RANKL. Data were analyzed using the Student t test.

Results: miR-335-5p acted as a positive mediator in HPDLF inflammation (P < .05). Two targets of miR-335-5p, uPAR and RANKL, were identified. Interestingly, uPAR was repressed by miR-335-5p at the basal level, but it can be relieved from miR-335-5p-mediated repression, which is called derepression, when HPDLFs were subjected to lipopolysaccharide stimulation. miR-335-5p promoted RANKL in HPDLFs regardless of whether or not it was under inflammatory conditions (P < .05). We proved FXR1 was responsible for the derepression of uPAR from miR-335-5p (P < .01). Both FXR1 and uPAR were positive mediators in HPDLF inflammation (P < .05). miR-335-5p, uPAR, RANKL, and FXR1 had the same expression profiles in HPDLF inflammation and AP tissues (P < .05).

Conclusions: Our data showed that miR-335-5p may play dual roles in AP, and it might be considered as a target for therapeutic potency in clinical applications.

Keywords: Apical periodontitis; fragile X–related 1 gene; microRNA-335-5p; receptor activator of nuclear factor kappa-B ligand; urokinase-type plasminogen activator receptor.

MeSH terms

  • Bone Resorption / metabolism
  • Enzyme-Linked Immunosorbent Assay
  • Fibroblasts / metabolism*
  • Humans
  • Inflammation / metabolism
  • Interleukin-6 / metabolism
  • MicroRNAs / metabolism*
  • Periapical Periodontitis / metabolism*
  • Periodontal Ligament / metabolism*
  • RANK Ligand / metabolism*
  • RNA-Binding Proteins / metabolism
  • Real-Time Polymerase Chain Reaction
  • Receptors, Urokinase Plasminogen Activator / metabolism
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • FXR1 protein, human
  • Interleukin-6
  • MicroRNAs
  • RANK Ligand
  • RNA-Binding Proteins
  • Receptors, Urokinase Plasminogen Activator
  • Tumor Necrosis Factor-alpha